184 related articles for article (PubMed ID: 33536745)
1. CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma.
Lin J; Qin H; Han Y; Li X; Zhao Y; Zhai G
Drug Des Devel Ther; 2021; 15():323-330. PubMed ID: 33536745
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
[TBL] [Abstract][Full Text] [Related]
3. MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1.
Zhou X; Zheng L; Zeng C; Wu Y; Tang X; Zhu Y; Tang S
Anticancer Drugs; 2023 Jan; 34(1):135-143. PubMed ID: 36539366
[TBL] [Abstract][Full Text] [Related]
4. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
5. HOTAIR mediates cisplatin resistance in nasopharyngeal carcinoma by regulating miR-106a-5p/SOX4 axis.
Cao W; Sun Y; Liu L; Yu J; Ji J; Wang Y; Yang J
Bioengineered; 2022 Mar; 13(3):6567-6578. PubMed ID: 35227173
[TBL] [Abstract][Full Text] [Related]
6. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma.
Li J; Hu C; Chao H; Zhang Y; Li Y; Hou J; Huang L
J Cell Mol Med; 2021 Oct; 25(19):9183-9198. PubMed ID: 34469038
[TBL] [Abstract][Full Text] [Related]
7. Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
Li D; Li X; Fan G; Bian G
Head Neck; 2022 Jul; 44(7):1631-1645. PubMed ID: 35460538
[TBL] [Abstract][Full Text] [Related]
8. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
9. Guggulsterone Promotes Nasopharyngeal Carcinoma Cells Exosomal Circfip1L1 to Mediate miR-125a-5p/VEGFA Affecting Tumor Angiogenesis.
Zhou T; Zhao S; Tang S; Wang Y; Wu R; Zeng X; Yang P; Zhang X; Tian X
Curr Mol Pharmacol; 2023; 16(8):870-880. PubMed ID: 36635928
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p.
Cui Z; Pu T; Zhang Y; Wang J; Zhao Y
Open Biol; 2020 May; 10(5):190286. PubMed ID: 32397872
[TBL] [Abstract][Full Text] [Related]
11. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1.
Xu X; Yan H; Zhang L; Liu J; Huang Y; Cheng H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458967
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
Hu W; Li H; Wang S
BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
[TBL] [Abstract][Full Text] [Related]
14. CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis.
He W; Zhou X; Mao Y; Wu Y; Tang X; Yan S; Tang S
Eur J Med Res; 2022 Apr; 27(1):59. PubMed ID: 35484574
[TBL] [Abstract][Full Text] [Related]
15. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HEIH modulates CDK8 expression by inhibiting miR-193a-5p to accelerate nasopharyngeal carcinoma progression.
Han YE; Tao JM; Wang SX; Ju X; Song ZY
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):770-778. PubMed ID: 33577031
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA SET domain protein 3 promotes nasopharyngeal carcinoma proliferation, cisplatin resistance, and protein kinase B / mammalian target of rapamycin pathway activation by modulating microRNA-147a expression.
Deng G; Wang F; Song Y
Bioengineered; 2022 Mar; 13(3):5843-5854. PubMed ID: 35196205
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
[TBL] [Abstract][Full Text] [Related]
19. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.
Wang J; Kong J; Nie Z; Chen D; Qiang J; Gao W; Chen X
Int J Med Sci; 2020; 17(11):1499-1507. PubMed ID: 32669952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
